<SEC-DOCUMENT>0001493152-23-033782.txt : 20230926
<SEC-HEADER>0001493152-23-033782.hdr.sgml : 20230926
<ACCEPTANCE-DATETIME>20230926173747
ACCESSION NUMBER:		0001493152-23-033782
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230922
FILED AS OF DATE:		20230926
DATE AS OF CHANGE:		20230926

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Corvus Capital Ltd.
		CENTRAL INDEX KEY:			0001990829
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41245
		FILM NUMBER:		231281411

	BUSINESS ADDRESS:	
		STREET 1:		WILLOW HOUSE, CRICKET SQUARE PO BOX 709
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1 - 1107
		BUSINESS PHONE:		44 7766 766766

	MAIL ADDRESS:	
		STREET 1:		WILLOW HOUSE, CRICKET SQUARE PO BOX 709
		CITY:			GRAND CAYMAN
		STATE:			E9
		ZIP:			KY1 - 1107

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Regan Andrew
		CENTRAL INDEX KEY:			0001991325

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41245
		FILM NUMBER:		231281412

	MAIL ADDRESS:	
		STREET 1:		LE MANOIR DE LURIN
		CITY:			SAINT BARTHELEMY
		STATE:			Z0
		ZIP:			97133

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Algo Holdings, Inc.
		CENTRAL INDEX KEY:			0001991236
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41245
		FILM NUMBER:		231281410

	BUSINESS ADDRESS:	
		STREET 1:		100 W. CYPRESS CREEK ROAD, STE. 640
		CITY:			FORT LAUDERDALE
		STATE:			NY
		ZIP:			33309
		BUSINESS PHONE:		1 (954) 294-9421

	MAIL ADDRESS:	
		STREET 1:		100 W. CYPRESS CREEK ROAD, STE. 640
		CITY:			FORT LAUDERDALE
		STATE:			NY
		ZIP:			33309

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CONDUIT PHARMACEUTICALS INC.
		CENTRAL INDEX KEY:			0001896212
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				873272543
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		4995 MURPHY CANYON ROAD, SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123
		BUSINESS PHONE:		(760) 471 8536

	MAIL ADDRESS:	
		STREET 1:		4995 MURPHY CANYON ROAD, SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92123

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Murphy Canyon Acquisition Corp.
		DATE OF NAME CHANGE:	20211130
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2023-09-22</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001896212</issuerCik>
        <issuerName>CONDUIT PHARMACEUTICALS INC.</issuerName>
        <issuerTradingSymbol>CDT</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001991325</rptOwnerCik>
            <rptOwnerName>Regan Andrew</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>4995 MURPHY CANYON ROAD, SUITE 300</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN DIEGO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92123</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001990829</rptOwnerCik>
            <rptOwnerName>Corvus Capital Ltd.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>4995 MURPHY CANYON ROAD, SUITE 300</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN DIEGO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92123</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>1</isOther>
            <officerTitle></officerTitle>
            <otherText>See Responses</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001991236</rptOwnerCik>
            <rptOwnerName>Algo Holdings, Inc.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>4995 MURPHY CANYON ROAD, SUITE 300</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>SAN DIEGO</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>92123</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>1</isOther>
            <officerTitle></officerTitle>
            <otherText>See Responses</otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock, par value $0.0001 per share (&quot;Shares&quot;)</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>66650</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F1"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Shares</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>45527149</value>
                    <footnoteId id="F2"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                    <footnoteId id="F3"/>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>See footnotes</value>
                    <footnoteId id="F2"/>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Reflects 66,650 Shares received by Dr. Regan as consideration in respect of the convertible promissory notes of Conduit Pharmaceuticals Limited (&quot;Conduit&quot;) held by him pursuant to the Agreement and Plan of Merger (&quot;Merger Agreement&quot;), dated as of November 8, 2022 and as amended on January 27, 2023 and May 11, 2023, by and among the Company, Conduit and Conduit Merger Sub, Inc., a Cayman Islands exempted company and a wholly-owned subsidiary of MURF (the &quot;Merger Sub&quot;). As a result of, and upon consummation of the transactions contemplated by, the Merger Agreement, the Company changed its name from &quot;Murphy Canyon Acquisition Corp.&quot; to &quot;Conduit Pharmaceuticals Inc.&quot;</footnote>
        <footnote id="F2">Reflects 31,148,454 Shares issued to Corvus Capital Ltd. and 14,378,695 Shares issued to Algo Holdings, Inc., which were received by such holders as consideration pursuant to the Merger Agreement.</footnote>
        <footnote id="F3">Dr. Regan is the Chief Executive Officer of Corvus Capital Ltd., and Algo Holdings, Inc. is a wholly owned subsidiary of Corvus Capital Ltd. By virtue of this relationship, Dr. Regan may be deemed to share beneficial ownership of the securities held of record by each of Corvus Capital Ltd. and Algo Holdings, Inc. Dr. Regan disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Andrew Regan</signatureName>
        <signatureDate>2023-09-26</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Corvus Capital Ltd. /s/ Andrew Regan, Chief Executive Officer</signatureName>
        <signatureDate>2023-09-26</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Algo Holdings, Inc. /s/ Alexander Lambert, Sole Director</signatureName>
        <signatureDate>2023-09-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
